Avanir Pharmaceuticals Earnings Conference Call (Q1 2013)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Feb 7 Calls Today's Calls

Call Details Avanir Pharmaceuticals Earnings Conference Call (Q1 2013) Scheduled to start Thu, Feb 7, 2013, 4:30 pm Eastern -- this event is ongoing now-- Listen to the ongoing live event audio stream About Avanir Pharmaceuticals Inc (NasdaqGS:AVNR) Other Calls  AVANIR Pharmaceuticals, Inc. focuses on acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States and Canada. Its lead product candidate includes Zenviatm, which has completed three Phase III clinical trials for the treatment of pseudobulbar affect; and a Phase III trial for the treatment of patients with diabetic peripheral neuropathic pain. The company also offers Abreva, an over-the-counter product for the treatment of cold sores. AVANIR Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Aliso Viejo, California. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings